Searchable abstracts of presentations at key conferences in endocrinology

ea0094s3.2 | Emerging perspectives on reproductive hormones in breast and prostate cancer | SFEBES2023

Androgen receptor interactions in endocrine resistant breast cancer - location, location, location

Bleach Rachel , Bozkurt Emir , Dussmann Heiko , Agbana Stephanie , Shirran Sally , Prehn Jochen , McIlroy Marie

IntroductionAromatase Inhibitors (AI) are standard therapy for hormone receptor positive breast cancers in post-menopausal patients. Unfortunately, resistance is common and previous studies from our lab suggest that the altered steroid environment may be a driver. Using label-free mass spectrometry we set out to explore the unique androgen receptor (AR) interactome that supervenes in AI resistant breast cancer and associated hyper-androgenic environment....

ea0070aep283 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Identification of a diagnostic and prognostic miRNA signature in women with gestational diabetes mellitus

Sanchez-Lechuga Begoña , Pfeiffer Shonna , Halang Luise , Prehn Jochen HM , Campos-Caro Antonio , Byrne Maria M , López-Tinoco Cristina

Gestational Diabetes Mellitus (GDM) is characterized by insulin resistance accompanied byreduced beta-cell compensation to increased insulin demand, typically observed in the secondand third trimester and associated with adverse pregnancy outcomes. There is a need for abiomarker that can accurately diagnose GDM, predict onset and accurately monitor status, reducing foetal-maternal morbidity and mortality risks. To this end, circulating microRNAs(miRNAs) present themselves as p...